Mitsubishi UFJ Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $252K | Buy |
49,910
+11,620
| +30% | +$58.6K | ﹤0.01% | 947 |
|
2025
Q1 | $248K | Buy |
38,290
+3,209
| +9% | +$20.8K | ﹤0.01% | 936 |
|
2024
Q4 | $263K | Buy |
35,081
+9,311
| +36% | +$69.8K | ﹤0.01% | 946 |
|
2024
Q3 | $193K | Sell |
25,770
-2,430
| -9% | -$18.2K | ﹤0.01% | 970 |
|
2024
Q2 | $251K | Buy |
28,200
+4,221
| +18% | +$37.6K | ﹤0.01% | 936 |
|
2024
Q1 | $243K | Sell |
23,979
-1,099
| -4% | -$11.1K | ﹤0.01% | 941 |
|
2023
Q4 | $253K | Buy |
25,078
+14,271
| +132% | +$144K | ﹤0.01% | 986 |
|
2023
Q3 | $101K | Hold |
10,807
| – | – | ﹤0.01% | 1084 |
|
2023
Q2 | $265K | Buy |
10,807
+857
| +9% | +$21K | ﹤0.01% | 1002 |
|
2023
Q1 | $232K | Buy |
9,950
+648
| +7% | +$15.1K | ﹤0.01% | 1010 |
|
2022
Q4 | $232K | Sell |
9,302
-641
| -6% | -$16K | ﹤0.01% | 1007 |
|
2022
Q3 | $192K | Hold |
9,943
| – | – | ﹤0.01% | 1028 |
|
2022
Q2 | $253K | Sell |
9,943
-40
| -0.4% | -$1.02K | ﹤0.01% | 1016 |
|
2022
Q1 | $257K | Buy |
9,983
+635
| +7% | +$16.3K | ﹤0.01% | 1022 |
|
2021
Q4 | $368K | Buy |
9,348
+2,383
| +34% | +$93.8K | ﹤0.01% | 988 |
|
2021
Q3 | $303K | Buy |
6,965
+184
| +3% | +$8.01K | ﹤0.01% | 1010 |
|
2021
Q2 | $321K | Sell |
6,781
-6,515
| -49% | -$308K | ﹤0.01% | 1030 |
|
2021
Q1 | $682K | Buy |
13,296
+4,497
| +51% | +$231K | ﹤0.01% | 843 |
|
2020
Q4 | $236K | Buy |
+8,799
| New | +$236K | ﹤0.01% | 936 |
|